Longview Acquisition Corp. (LGVW.UN1)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
CEO:
Todd M. Fruchterman
Employees:
460
530 OLD WHITFIELD STREET, GUILFORD, CT 06437
203-689-5650

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; Butterfly Blueprint, a system-wide ultrasound platform with Compass software. The company also provides Butterfly system, which includes probes, and related accessories and software subscriptions.

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 18.543 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.27
Price to Revenue8.9499 Debt to Equity0.0 EBITDA-107.595 Million
Price to Book Value1.5831 Operating Margin-292.817 Enterprise Value301.354 Million
Current Ratio6.84 EPS Growth0.97 Quick Ratio5.2
1 Yr BETA 0.4323 52-week High/Low 0.0 / Profit Margin-159.4418
Operating Cash Flow Growth-31.8261 Altman Z-Score2.1883 Free Cash Flow to Firm -279.227 Million
View SEC Filings from LGVW.UN1 instead.

View recent insider trading info

Longview Acquisition Corp. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding LGVW.UN1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LGVW.UN1

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-06-22 by SCHWARTZ ERICA
  • 4: filed on 2022-06-22 by CARFORA DAWN
  • 4: filed on 2022-06-22 by EDELMAN ELAZER R
  • 4: filed on 2022-06-01 by DILLON TAMARA
  • 3: filed on 2022-06-01 by DILLON TAMARA
  • 4: filed on 2021-09-20 by QUANDER TROY
  • 3: filed on 2021-09-20 by QUANDER TROY
  • 4: filed on 2021-09-10 by SCHWARTZ ERICA
  • 3: filed on 2021-09-10 by SCHWARTZ ERICA
  • 4: filed on 2021-07-21 by STOICA ANDREI G

    • Events (8k)

  • 8-K: filed on 2023-03-17:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-10:
    Item 8.01: Other Events
  • 8-K: filed on 2023-02-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-24:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-01-11:
    Item 2.05: Cost Associated with Exit or Disposal Activities
  • 8-K: filed on 2022-12-29:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-12-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-11-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-03:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    EDELMAN ELAZER R

    • Director
    		 63,329 2022-06-17 1

    CARFORA DAWN

    • Director
    		 73,397 2022-06-17 1

    PETTITI GIANLUCA

    • Director
    		 79,402 2022-06-17 1

    SCHWARTZ ERICA

    • Director
    		 72,135 2022-06-17 1

    DILLON TAMARA CHIEF PEOPLE OFFICER

    • Officer
    		 0 2022-05-31 2

    QUANDER TROY SVP, REGULATORY AND QUALITY

    • Officer
    		 57,241 2021-09-16 0

    STOICA ANDREI G CHIEF TECHNOLOGY OFFICER

    • Officer
    		 0 2021-07-19 0

    ROTHBERG JONATHAN M

    • Director
    • 10% Owner
    		 0 2021-02-12 0

    HAMMERGREN JOHN H

    • Director
    		 0 2021-02-12 0

    PHANSTIEL S. LOUISE

    • Director
    		 0 2021-02-12 0

    FRUCHTERMAN TODD PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2021-02-12 0

    PERRI DAVID CHIEF OPERATING OFFICER

    • Officer
    		 0 2021-02-12 0

    MOLINARI GIOEL EVP & CPO

    • Officer
    		 0 2021-02-12 0

    SHAHIDA DARIUS CSO & CBDO

    • Officer
    		 0 2021-02-12 0

    FIELDING STEPHANIE CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2021-02-12 0

    MILLER MARY GC AND CS

    • Officer
    		 0 2021-02-12 0

    ROBBINS LARRY

    LONGVIEW INVESTORS LLC

    • Director
    • 10% Owner
    		 0 2020-05-20 0

    MOORE WESTLEY

    • Director
    		 0 2020-05-20 0

    SIMPSON RANDY

    • Director
    		 0 2020-05-20 0

    CRIBBS DEREK

    • Director
    		 0 2020-05-20 0

    RODIN JOHN CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2020-05-20 0

    HOROWITZ MARK J. CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2020-05-20 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments